Presbyopia eye drop in final stage of clinical development An ophthalmic pharmaceutical company has commenced two Phase 3 clinical studies to evaluate its eye drop candidate for presbyopia.Read More Myles HumeJanuary 13, 2021, 7:21 amJanuary 13, 2021
